Serum Neurofilament light chain as a predictor of long-term outcomes in patients with CIS in the BENEFIT 11 trial

被引：0
|
作者：
Kuhle, J. [1 ,2 ,3 ]
Barro, C. [1 ,2 ,3 ]
Edan, G. [4 ]
Freedman, M. S. [5 ,6 ]
Hartung, H-P. [7 ]
Montalban, X. [8 ]
Barkhof, F. [9 ]
Fox, E. J. [10 ]
Hemmer, B. [11 ,12 ]
Schippling, S. [13 ]
Koelbach, R. [14 ]
Wicklein, E-M. [15 ]
Kappos, L. [16 ,17 ,18 ]
机构：
[1] Univ Basel, Univ Basel Hosp, Neurol Clin & Policlin, Dept Med, Basel, Switzerland
[2] Univ Basel, Univ Basel Hosp, Neurol Clin & Policlin, Dept Biomed, Basel, Switzerland
[3] Univ Basel, Univ Basel Hosp, Neurol Clin & Policlin, Dept Clin Res, Basel, Switzerland
[4] CHU Pontchaillou, Rennes, France
[5] Univ Ottawa, Ottawa, ON, Canada
[6] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[7] Heinrich Heine Univ, Fac Med, Dept Neurol, Dusseldorf, Germany
[8] Hosp Univ Vall dHebron, Barcelona, Spain
[9] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[10] Cent Texas Neurol Consultants, Round Rock, TX USA
[11] Tech Univ Munich, Munich, Germany
[12] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[13] Univ Hosp Zurich, Zurich, Switzerland
[14] PAREXEL Int, Berlin, Germany
[15] Bayer AG, Berlin, Germany
[16] Univ Hosp Basel, Neurol, Dept Med, Basel, Switzerland
[17] Univ Hosp Basel, Neurol, Dept Biomed, Basel, Switzerland
[18] Univ Hosp Basel, Neurol, Dept Clin Res, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1613
引用
收藏
页码：844 / 845
页数：2
相关论文
共 50 条
  • [21] Long term MS clinical outcomes predicted by baseline serum neurofilament light levels
    Abdoli, M.
    Thebault, S.
    Freedman, M. S.
    Fereshtehnejad, S. M.
    Tabard-Cossa, V.
    Tessier, D. R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 506 - 507
  • [22] Serum Neurofilament Light Chain as a Marker of Progression in Parkinson's Disease: Long-Term Observation and Implications of Clinical Subtypes
    Rodstrom, Emil Ygland
    Mattsson-Carlgren, Niklas
    Janelidze, Shorena
    Hansson, Oskar
    Puschmann, Andreas
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (02) : 571 - 584
  • [23] Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
    Sjolin, Karl
    Aulin, Julia
    Wallentin, Lars
    Eriksson, Niclas
    Held, Claes
    Kultima, Kim
    Oldgren, Jonas
    Burman, Joachim
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (14):
  • [24] Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen
    Cordts, Isabell
    Fuetterer, Cornelia
    Wachinger, Annika
    von Heynitz, Ricarda
    Kessler, Tobias
    Freigang, Maren
    Quinten, Anna Lisa
    Bjelica, Bogdan
    Brakemeier, Svenja
    Hobbiebrunken, Elke
    Hagenacker, Tim
    Petri, Susanne
    Koch, Jan Christoph
    Hahn, Andreas
    Lingor, Paul
    Deschauer, Marcus
    Guenther, Rene
    Weiler, Markus
    Haller, Bernhard
    Feneberg, Emily
    NEUROLOGY, 2025, 104 (05)
  • [25] Serum Cystatin C as a Predictor of Early Outcomes and Long-Term Mortality in Contemporary LVAD Patients
    Mondellini, G. M.
    Pinsino, A.
    Braghieri, L.
    Javaid, A.
    Lin, E. F.
    Cagliostro, B.
    Pineda, M. F.
    Fried, J. A.
    Topkara, V.
    Takeda, K.
    Naka, Y.
    Sayer, G.
    Uriel, N.
    Radhakrishnan, J.
    Demmer, R.
    Colombo, P. C.
    Yuzefpolskaya, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S182 - S182
  • [26] Serum neurofilament light chain as a predictor of response in a multicentric cohort of multiple sclerosis patients treated with Ocrelizumab
    Rodriguez Jorge, Fernando
    Fernandez Velasco, Jose Ignacio
    Villarrubia, Noelia
    Gracia-Gil, Julia
    Fernandez Diaz, Eva
    Bau Vila, Laura
    Martinez Yelamos, Sergio
    Diaz Perez, Carolina
    Meca, Virginia
    Sainz De la Maza, Susana
    Pacheco Cortegana, Eva Maria
    Monreal, Enric
    Borrega Canelo, Laura
    Chico Garcia, Juan Luis
    Lopez Real, Ana Maria
    Sainz, Raquel
    Barrero Hernandez, Francisco Javier
    Martinez-Gines, Maria Isabel
    De la Fuente, Soraya
    Moreno Torres, Irene
    Caminero Rodriguez, Ana Belen
    Castellanos Pinedo, Fernando
    Ayuso, Lucia
    Abreu, Rossana
    Meca Lallana, Jose
    Quiroga-Varela, Ana
    Ramio I Torrenta, Lluis
    Masjuan, Jaime
    Costa-Frossard, Lucienne
    Villar Guimerans, Luisa Maria
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 642 - 643
  • [27] Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode
    Plavina, Tatiana
    Singh, Carol M.
    Sangurdekar, Dipen
    de Moor, Carl
    Engle, Bob
    Gafson, Arie
    Goyal, Jaya
    Fisher, Elizabeth
    Szak, Suzanne
    Kinkel, Revere P.
    Sandrock, Alfred W.
    Su, Ray
    Kieseier, Bernd C.
    Rudick, Richard A.
    JAMA NETWORK OPEN, 2020, 3 (11)
  • [28] Serum neurofilament light chain (NfL)and CSF glial fibrillary acidic protein (GFAP) together improve the prediction of long-term clinical outcomes in multiple sclerosis
    Thebault, Simon
    Fereshtehnejad, Seyed Mohammad
    Bergman, Hailey
    Bose, Gauruv
    Freedman, Mark
    NEUROLOGY, 2023, 100 (17)
  • [29] Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years
    Canto, Ester
    Barro, Christian
    Zhao, Chao
    Caillier, Stacy J.
    Michalak, Zuzanna
    Bove, Riley
    Tomic, Davorka
    Santaniello, Adam
    Haering, Dieter A.
    Hollenbach, Jill
    Henry, Roland G.
    Cree, Bruce A. C.
    Kappos, Ludwig
    Leppert, David
    Hauser, Stephen L.
    Benkert, Pascal
    Oksenberg, Jorge R.
    Kuhle, Jens
    JAMA NEUROLOGY, 2019, 76 (11) : 1359 - 1366
  • [30] Associations of Serum Neurofilament Light Chain with Outcomes in Children with Autoimmune Encephalitis
    Da Silva, Susana
    Yea, Carmen
    Madani, Jihan
    Wagner, Matt
    Longoni, Giulia
    Branson, Helen M.
    Vidarsson, Logi
    Ertl-Wagner, Birgit
    Yeh, E. Ann
    NEUROLOGY, 2023, 100 (17)
12345